BIOXYTRAN, INC Research And Development Expense

Quick Answer

BIOXYTRAN, INC reported Research And Development Expense of $112.3 thousand for the year ending 2024.

  • BIOXYTRAN, INC showed a decrease of -90.2% in Research And Development Expense from 2023 to 2024.
  • This data is from BIOXYTRAN, INC's annual report (Form 10-K), filed with the SEC on April 3, 2025.
  • XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2020 to 2024), BIOXYTRAN, INC's Research And Development Expense has declined by 79.4%.
  • Historical annual values: Fiscal year 2024: $112.3 thousand | Fiscal year 2023: $1.15 million | Fiscal year 2022: $977.8 thousand | Fiscal year 2021: $2.01 million | Fiscal year 2020: $544.5 thousand.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: